Peking University Clinical Trial Pipeline: 98 Active Trials, 11 Changes This Month

What changed in the last 30 days

7 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 5 with minor changes only.

Stopped

Weight Management Program for Obese Preschool Children

Trial status changed: Not Yet Recruiting → Terminated

Sponsor's reason: Study terminated prematurely due to poor accrual. The actual number of eligible children recruited from kindergartens was far lower than expected, making the study unfeasible.

Also in this update: Final enrollment: 25 participants (planned 200); Primary completion date changed from estimate of Jun 30, 2026 to Nov 30, 2025

Peking UniversityNot applicable NCT07126210 Registry history of NCT07126210 on ClinicalTrials.gov (opens the registry)

Updated Sep 16, 2026
Notable

Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District

Enrollment reopened

Peking UniversityNot applicable NCT07804420 Registry history of NCT07804420 on ClinicalTrials.gov (opens the registry)

Updated Sep 16, 2026

Show 5 trials with minor changes only

Minor

RESOLVE-2 · Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric Adenocarcinoma

Primary completion pushed from Aug 30, 2026 to Sep 30, 2026

Peking UniversityPhase 2/3 NCT03691454 Registry history of NCT03691454 on ClinicalTrials.gov (opens the registry)

Updated Sep 21, 2026
Minor

FAN · Gshan Active Nutrition Initiative

Primary completion moved earlier from Apr 20, 2028 to Sep 10, 2027

Also in this update: Study completion moved earlier from Apr 30, 2029 to Sep 30, 2028

Peking UniversityNot applicable NCT07519122 Registry history of NCT07519122 on ClinicalTrials.gov (opens the registry)

Updated Sep 21, 2026
Minor
3 trials marked Unknown by the registry's verification sweep
1. Minor
  
  Mechanisms of Mindfulness Intervention: Cognitive Flexibility Dose Manipulation
  
  Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  
  Peking UniversityNot applicable NCT06622122 Registry history of NCT06622122 on ClinicalTrials.gov (opens the registry)
  
  Changed Oct 4, 2026
2. Minor
  
  Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
  
  Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
  
  Peking UniversityNot specified NCT06071403 Registry history of NCT06071403 on ClinicalTrials.gov (opens the registry)
  
  Changed Oct 4, 2026
3. Minor
  
  Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants
  
  Registry marked status Unknown (sponsor has not verified the record since Apr 2022); last known: Recruiting
  
  Peking UniversityNot applicable NCT02880891 Registry history of NCT02880891 on ClinicalTrials.gov (opens the registry)
  
  Changed Oct 4, 2026
Registry verification sweep

Changed Oct 4, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First posted	Trial	Phase	Status
2026-09-16	NCT07822867 Effects of an Exercise Snacking Intervention on Cognitive Function in Patients With Mild…		Not Yet Recruiting
2026-09-16	NCT07823114 EMI for Reducing Psychological Distress in Young Adults With Multiple ACEs: A Feasibility…		Not Yet Recruiting

Active trials by phase

Early Phase 1		4
Phase 1		9
Phase 2		13
Phase 2/3		1
Phase 3		2
Phase 4		2

Not charted: 67 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 98

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT07646886	Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis	Facial Aging	Not Yet Recruiting	2026-07-07
NCT06963593	Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and…	Advanced Gastroesophageal Cancer	Not Yet Recruiting	2025-05-09
Phase 3
NCT02535221	Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ &…	Breast Cancer	Recruiting	2021-11-29
NCT07677293	Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1…	Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma	Not Yet Recruiting	2026-06-30
Phase 2/3
NCT03691454	Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in…	Gastric Adenocarcinoma	Active, Not Recruiting	2026-09-21
Phase 2
NCT07127822	Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric…	Gastric / Gastroesophageal Junction Adenocarcinoma	Recruiting	2026-08-05
NCT06580574	Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric…	Gastric Cancer	Recruiting	2026-05-15
NCT05165407	Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC…	Neuroendocrine Neoplasm	Recruiting	2025-03-14
NCT06684600	Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced…	Esophageal Squamous Cell Carcinoma	Recruiting	2024-11-12
NCT06023758	Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC	HER2-positive Locally Advanced Resectable Gastric Cancer	Recruiting	2024-05-10
NCT06347653	Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell…	Nodal T-follicular Helper Cell Lymphoma	Recruiting	2024-04-04
NCT04481932	Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast…	HER2-positive Breast Cancer	Recruiting	2020-07-22
NCT06650748	Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant…	Breast Cancer	Enrolling by Invitation	2026-03-17
NCT04556253	AK104 in Locally Advanced MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer	MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer	Active, Not Recruiting	2026-01-02
NCT07312578	Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of…	Esophageal Squamous Cell Carcinoma	Enrolling by Invitation	2025-12-31
NCT06772233	A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal…	Metastatic Gastrointestinal Stromal Tumors (GIST)	Not Yet Recruiting	2025-07-31
NCT05894889	Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC	Stage IIIB(N2) Non-small Cell Lung Cancer	Active, Not Recruiting	2025-07-23
NCT06745193	A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with…	Advanced Esophageal Carcinoma	Not Yet Recruiting	2024-12-20
Phase 1
NCT06134960	NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor	Gastric Cancer	Recruiting	2026-09-14
NCT06541639	EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors	Advanced or Recurrent Solid Tumors	Recruiting	2026-06-22
NCT07139067	Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors	Advanced Solid Tumor Cancer	Recruiting	2025-08-24
NCT06891742	Phase I Study of OriC902 in Treatment of Advanced HCC	HCC	Recruiting	2025-03-24
NCT06170294	MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors	Advanced Solid Tumor	Recruiting	2023-12-14
NCT07486700	The Phase I Study of SIG001 Antibody on Cancer Therapy.	Neoplams	Not Yet Recruiting	2026-03-20
NCT07454031	Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal…	Peritoneal (Metastatic) Cancer	Not Yet Recruiting	2026-03-13

See all 98 active Peking University trials with filters →

Disease areas by active trials, top 10 of 22

Depression (12) · Anxiety (10) · Gastric Cancer (10) · Esophageal Cancer (8) · Obesity (7) · PTSD (7) · Diabetes (6) · Hypertension (6) · Breast Cancer (5) · Type 2 Diabetes (4)

Peking University clinical trial pipeline

What changed in the last 30 days

Weight Management Program for Obese Preschool Children

Cluster-Randomized Trial of a Hypertension Risk Model-Based…Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District

RESOLVE-2 · Neoadjuvant DOS Combined With Toripalimab Versus…RESOLVE-2 · Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric Adenocarcinoma

FAN · Gshan Active Nutrition Initiative

Mechanisms of Mindfulness Intervention: Cognitive Flexibility Dose…Mechanisms of Mindfulness Intervention: Cognitive Flexibility Dose Manipulation

Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low…Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants

Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level…Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants

New trial filings, last 30 days

Active trials by phase

Active trials top 25 of 98

Disease areas by active trials, top 10 of 22

Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District

RESOLVE-2 · Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric Adenocarcinoma

Mechanisms of Mindfulness Intervention: Cognitive Flexibility Dose Manipulation

Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants

Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants